HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Goldbaum Selected Research

Therapeutics

7/2013Common variant in VEGFA and response to anti-VEGF therapy for neovascular age-related macular degeneration.
12/2008Pegaptanib sodium for neovascular age-related macular degeneration: third-year safety results of the VEGF Inhibition Study in Ocular Neovascularisation (VISION) trial.
9/2006Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Goldbaum Research Topics

Disease

4Macular Degeneration (Age-Related Maculopathy)
07/2013 - 09/2006
1Blindness (Hysterical Blindness)
09/2006
1Retinal Detachment (Retinal Detachments)
04/2000
1Atrophy
04/2000

Drug/Important Bio-Agent (IBA)

2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2013 - 12/2008
2pegaptanib (Macugen)FDA Link
12/2008 - 09/2006
1Lipase (Acid Lipase)FDA Link
02/2013
1Fluorescein (Funduscein)FDA LinkGeneric
04/2000
1LipidsIBA
04/2000

Therapy/Procedure

3Therapeutics
07/2013 - 09/2006